JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $7
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $9 to $7.
Login to comment